This report was recently updated on November 16 2024 with the latest and most recent
market numbers
Global Artificial Pancreas Market Size, Trends & Analysis - Forecasts to 2028 By Device Type (Threshold Suspend Device Systems, Control-to-range Systems, and Control-to-target Systems), By End User (Hospitals, Homecare, Ambulatory Surgical Centers (ASCs), and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global artificial pancreas market is estimated to exhibit a CAGR of 12.1% from 2023 to 2028.
The primary factors propelling the market growth are the increasing prevalence of diabetes and the rising demand for automated systems for glycemic control. The surge in diabetes cases, encompassing both type 1 and type 2 diabetes, has propelled the demand for advanced diabetes management technology, specifically artificial pancreas systems. These systems provide an integrated approach to glucose management, addressing the changing requirements of those living with diabetes. Artificial pancreas systems meet this need by offering a more simplified and effective method of managing diabetes due to its automated and real-time monitoring features. Additionally, cutting-edge technology has significantly shaped the market environment, including continuous glucose monitoring (CGM) systems and closed-loop insulin delivery. For instance, the World Health Organization (WHO) (2023) estimates that 422 million people worldwide have diabetes, with the majority living in low- and middle-income countries. Each year, the disease is directly responsible for 1.5 million deaths.
Rising product approvals, the launch of innovative products, and technological advancements in continuous glucose monitoring solutions are expected to support the market growth over the forecast period. The approval and introduction of new artificial pancreas systems signify advancements in Type 1 diabetes treatment. These devices meet the changing demands of people with Type 1 diabetes by offering increasingly advanced and automated methods of glucose management. Moreover, the approval and introduction of innovative artificial pancreas systems highlight the increasing role of technology in automated diabetes care. The developments in insulin pump technology, which have led to more effective and customized diabetes care strategies, are a prime example of this integration. For instance, the Medtronic MiniMed 780G artificial pancreas device is authorized by the U.S. Food and Drug Administration (FDA) for use in patients who are seven years of age or older.
The growing demand for blood sugar monitoring and glucose control systems, coupled with a rising focus on improving patient outcomes, propels the market growth. Patient awareness of the benefits of continuous glucose management and blood sugar monitoring drives demand for artificial pancreas devices. Patients are looking for solutions that use hybrid closed-loop systems to give automatic modifications and precise monitoring. It can be difficult to control diabetes traditionally, as it requires regular blood sugar readings, manual insulin injections, and continuous dose changes. By automating a large portion of the management procedure, artificial pancreas devices improve the quality of life and independence for people with diabetes.
Advances in data analytics, automated insulin delivery systems, and sensor technologies can create new opportunities for artificial pancreas systems, expanding their use and meeting a range of patient requirements. Moreover, diabetes care innovation, particularly in advanced continuous glucose monitoring (CGM), provides an opportunity for increased adoption of artificial pancreas systems. Incorporating advanced CGM technology makes these devices more appealing to users looking for more precise and real-time glucose monitoring.
However, market growth is being impeded by strict regulatory frameworks and the expensive cost of artificial pancreas systems.
The threshold suspend device systems segment is expected to hold the largest share of the market over the forecast period. Threshold suspend device systems are made to stop delivering insulin automatically when blood glucose levels get close to a certain point. This function lessens the possibility of hypoglycemia or low blood sugar, which is dangerous for those who have diabetes. The device's safety profile is improved by its ability to halt insulin administration at a predetermined threshold, as hypoglycemia can have serious repercussions. Moreover, threshold suspend technology has been supported by clinical evidence demonstrating its efficacy in preventing hypoglycemia while maintaining glucose control. Positive outcomes from clinical trials and empirical data support the legitimacy and uptake of threshold suspend device systems among diabetics and medical experts.
The control-to-target systems segment is expected to be the fastest-growing segment in the market from 2023-2028. Control-to-target systems provide a more proactive and precise method of managing diabetes by attempting to keep blood glucose levels within a given target range. The focus on better glucose management appeals to diabetes patients and healthcare professionals since stable blood sugar levels are essential to diabetes treatment. Moreover, advanced algorithms that optimize insulin administration based on real-time glucose measurements are frequently included in control-to-target systems. Due to these algorithms' complexity, personalized and dynamic adaptations are possible, accounting for daily activities and individual differences in insulin sensitivity.
The hospitals segment is expected to hold the largest share of the market. Training patients and medical personnel is a common step in implementing artificial pancreas systems. Hospitals are well-positioned to support this training, guaranteeing that medical staff members comprehend the system's workings and that patients are well-instructed in its usage. This hands-on approach is crucial in the early stages of adoption. Clinical trials and research studies about artificial pancreas systems are also frequently carried out in hospitals. These studies add significant information on the technology's efficacy, safety, and practical performance, enhancing its legitimacy and acceptability in the medical field.
The ambulatory surgical centers (ASCs) segment is anticipated to be the fastest-growing segment in the market from 2023-2028. Ambulatory surgical centers are appropriate settings for certain aspects of diabetes care, such as the beginning and monitoring of artificial pancreas systems, as they frequently handle outpatient operations. This segment grows as the need for elective surgeries increases.
North America is expected to be the largest region in the global market. Adequate funding for healthcare in North America can impact payment guidelines, enabling patients and healthcare providers to afford the adoption of innovative technology. The rate at which artificial pancreas devices are adopted can be significantly impacted by well-defined reimbursement mechanisms. For instance, the 2021 National Health Expenditures (NHE) Report states that U.S. healthcare spending increased by 2.7% in 2021 to reach USD 4.3 trillion.
Asia Pacific is anticipated to witness rapid growth during the forecast period. In the Asia Pacific region, the prevalence of diabetes, both type 1 and type 2, has been rising. The demand for cutting-edge technology, including artificial pancreas systems, to improve glucose control and the quality of life for people with diabetes is expanding as the number of cases of the disease rises. For instance, in China, 13% of adults have diabetes, according to the International Diabetes Federation (IDF).
Medtronic PLC, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., Bigfoot Biomedical, Inc., DexCom, Inc., Beta Bionics, Inc., Admetsys Corp., Insulet Corporation, and Defymed among others, are some of the key players in the global artificial pancreas market.
Please note: This is not an exhaustive list of companies profiled in the report.
In 2022, at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Beta Bionics, Inc. reported positive results from the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial (IO BPPT).
In 2022, Medtronic launched MiniMed 780G, the next-generation closed-loop insulin pump system in India.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL ARTIFICIAL PANCREAS MARKET, BY DEVICE TYPE
4.1 Introduction
4.2 Artificial Pancreas Market: Device Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Threshold Suspend Device Systems
4.4.1 Threshold Suspend Device Systems Market Estimates and Forecast, 2020-2028 (USD Million)
4.5 Control-to-range Systems
4.5.1 Control-to-range Systems Market Estimates and Forecast, 2020-2028 (USD Million)
4.6 Control-to-target Systems
4.6.1 Control-to-target Systems Market Estimates and Forecast, 2020-2028 (USD Million)
5 GLOBAL ARTIFICIAL PANCREAS MARKET, BY END USER
5.1 Introduction
5.2 Artificial Pancreas Market: End User Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Hospitals
5.4.1 Hospitals Market Estimates and Forecast, 2020-2028 (USD Million)
5.5 Homecare
5.5.1 Homecare Market Estimates and Forecast, 2020-2028 (USD Million)
5.6 Ambulatory Surgical Centers (ASCs)
5.6.1 Ambulatory Surgical Centers (ASCs) Market Estimates and Forecast, 2020-2028 (USD Million)
5.7 Others
5.7.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
6 GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION
6.1 Introduction
6.2 North America Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.2.1 By Device Type
6.2.2 By End User
6.2.3 By Country
6.2.3.1 U.S. Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.2.3.1.1 By Device Type
6.2.3.1.2 By End User
6.2.3.2 Canada Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.2.3.2.1 By Device Type
6.2.3.2.2 By End User
6.2.3.3 Mexico Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.2.3.3.1 By Device Type
6.2.3.3.2 By End User
6.3 Europe Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.1 By Device Type
6.3.2 By End User
6.3.3 By Country
6.3.3.1 Germany Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.1.1 By Device Type
6.3.3.1.2 By End User
6.3.3.2 U.K. Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.2.1 By Device Type
6.3.3.2.2 By End User
6.3.3.3 France Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.3.1 By Device Type
6.3.3.3.2 By End User
6.3.3.4 Italy Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.4.1 By Device Type
6.3.3.4.2 By End User
6.3.3.5 Spain Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.5.1 By Device Type
6.3.3.5.2 By End User
6.3.3.6 Netherlands Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.6.1 By Device Type
6.3.3.6.2 By End User
6.3.3.7 Rest of Europe Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.3.3.6.1 By Device Type
6.3.3.6.2 By End User
6.4 Asia Pacific Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.1 By Device Type
6.4.2 By End User
6.4.3 By Country
6.4.3.1 China Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.1.1 By Device Type
6.4.3.1.2 By End User
6.4.3.2 Japan Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.2.1 By Device Type
6.4.3.2.2 By End User
6.4.3.3 India Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.3.1 By Device Type
6.4.3.3.2 By End User
6.4.3.4 South Korea Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.4.1 By Device Type
6.4.3.4.2 By End User
6.4.3.5 Singapore Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.5.1 By Device Type
6.4.3.5.2 By End User
6.4.3.6 Malaysia Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.6.1 By Device Type
6.4.3.6.2 By End User
6.4.3.7 Thailand Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.6.1 By Device Type
6.4.3.6.2 By End User
6.4.3.8 Indonesia Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.7.1 By Device Type
6.4.3.7.2 By End User
6.4.3.9 Vietnam Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.8.1 By Device Type
6.4.3.8.2 By End User
6.4.3.10 Taiwan Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.10.1 By Device Type
6.4.3.10.2 By End User
6.4.3.11 Rest of Asia Pacific Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.4.3.11.1 By Device Type
6.4.3.11.2 By End User
6.5 Middle East and Africa Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.1 By Device Type
6.5.2 By End User
6.5.3 By Country
6.5.3.1 Saudi Arabia Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.3.1.1 By Device Type
6.5.3.1.2 By End User
6.5.3.2 U.A.E. Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.3.2.1 By Device Type
6.5.3.2.2 By End User
6.5.3.3 Israel Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.3.3.1 By Device Type
6.5.3.3.2 By End User
6.5.3.4 South Africa Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.3.4.1 By Device Type
6.5.3.4.2 By End User
6.5.3.5 Rest of Middle East and Africa Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.3.5.1 By Device Type
6.5.3.5.2 By End User
6.6 Central and South America Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.1 By Device Type
6.6.2 By End User
6.6.3 By Country
6.6.3.1 Brazil Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.3.1.1 By Device Type
6.6.3.1.2 By End User
6.6.3.2 Argentina Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.3.2.1 By Device Type
6.6.3.2.2 By End User
6.6.3.3 Chile Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.3.3.1 By Device Type
6.6.3.3.2 By End User
6.6.3.3 Rest of Central and South America Artificial Pancreas Market Estimates and Forecast, 2020-2028 (USD Million)
6.6.3.3.1 By Device Type
6.6.3.3.2 By End User
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Medtronic PLC
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Johnson & Johnson
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Tandem Diabetes Care, Inc.
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Pancreum, Inc
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Bigfoot Biomedical, Inc.
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 DEXCOM, INC.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Beta Bionics, Inc.
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Admetsys Corp.
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Insulet Corporation
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Defymed
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
2 Threshold Suspend Device Systems Market, By Region, 2020-2028 (USD Mllion)
3 Control-to-range Systems Market, By Region, 2020-2028 (USD Mllion)
4 Control-to-target Systems Market, By Region, 2020-2028 (USD Mllion)
5 Global Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
6 Hospitals Market, By Region, 2020-2028 (USD Mllion)
7 Homecare Market, By Region, 2020-2028 (USD Mllion)
8 Ambulatory Surgical Centers (ASCs) Market, By Region, 2020-2028 (USD Mllion)
9 OTHERS Market, By Region, 2020-2028 (USD Mllion)
10 Regional Analysis, 2020-2028 (USD Mllion)
11 North America Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
12 North America Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
13 North America Artificial Pancreas Market, By COUNTRY, 2020-2028 (USD Mllion)
14 U.S. Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
15 U.S. Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
16 Canada Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
17 Canada Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
18 Mexico Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
19 Mexico Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
20 Europe Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
21 Europe Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
22 EUROPE Artificial Pancreas Market, By COUNTRY, 2020-2028 (USD Mllion)
23 Germany Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
24 Germany Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
25 U.K. Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
26 U.K. Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
27 France Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
28 France Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
29 Italy Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
30 Italy Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
31 Spain Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
32 Spain Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
33 Netherlands Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
34 Netherlands Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
35 Rest Of Europe Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
36 Rest Of Europe Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
37 Asia Pacific Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
38 Asia Pacific Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
39 ASIA PACIFIC Artificial Pancreas Market, By COUNTRY, 2020-2028 (USD Mllion)
40 China Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
41 China Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
42 Japan Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
43 Japan Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
44 India Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
45 India Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
46 South Korea Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
47 South Korea Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
48 Singapore Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
49 Singapore Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
50 Thailand Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
51 Thailand Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
52 Malaysia Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
53 Malaysia Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
54 Indonesia Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
55 Indonesia Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
56 Vietnam Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
57 Vietnam Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
58 Taiwan Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
59 Taiwan Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
60 Rest of APAC Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
61 Rest of APAC Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
62 Middle East and Africa Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
63 Middle East and Africa Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
64 MIDDLE EAST & ADRICA Artificial Pancreas Market, By COUNTRY, 2020-2028 (USD Mllion)
65 Saudi Arabia Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
66 Saudi Arabia Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
67 UAE Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
68 UAE Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
69 Israel Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
70 Israel Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
71 South Africa Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
72 South Africa Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
73 Rest Of Middle East and Africa Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
74 Rest Of Middle East and Africa Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
75 Central and South America Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
76 Central and South America Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
77 CENTRAL AND SOUTH AMERICA Artificial Pancreas Market, By COUNTRY, 2020-2028 (USD Mllion)
78 Brazil Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
79 Brazil Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
80 Chile Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
81 Chile Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
82 Argentina Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
83 Argentina Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
84 Rest Of Central and South America Artificial Pancreas Market, By Device Type, 2020-2028 (USD Mllion)
85 Rest Of Central and South America Artificial Pancreas Market, By End User, 2020-2028 (USD Mllion)
86 Medtronic PLC: Products & Services Offering
87 Johnson & Johnson: Products & Services Offering
88 Tandem Diabetes Care, Inc.: Products & Services Offering
89 Pancreum, Inc: Products & Services Offering
90 Bigfoot Biomedical, Inc.: Products & Services Offering
91 DEXCOM, INC.: Products & Services Offering
92 Beta Bionics, Inc. : Products & Services Offering
93 Admetsys Corp.: Products & Services Offering
94 Insulet Corporation, Inc: Products & Services Offering
95 Defymed: Products & Services Offering
96 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Artificial Pancreas Market Overview
2 Global Artificial Pancreas Market Value From 2020-2028 (USD Mllion)
3 Global Artificial Pancreas Market Share, By Device Type (2022)
4 Global Artificial Pancreas Market Share, By End User (2022)
5 Global Artificial Pancreas Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Artificial Pancreas Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Artificial Pancreas Market
10 Impact Of Challenges On The Global Artificial Pancreas Market
11 Porter’s Five Forces Analysis
12 Global Artificial Pancreas Market: By Device Type Scope Key Takeaways
13 Global Artificial Pancreas Market, By Device Type Segment: Revenue Growth Analysis
14 Threshold Suspend Device Systems Market, By Region, 2020-2028 (USD Mllion)
15 Control-to-range Systems Market, By Region, 2020-2028 (USD Mllion)
16 Control-to-target Systems Market, By Region, 2020-2028 (USD Mllion)
17 Global Artificial Pancreas Market: By End User Scope Key Takeaways
18 Global Artificial Pancreas Market, By End User Segment: Revenue Growth Analysis
19 Hospitals Market, By Region, 2020-2028 (USD Mllion)
20 Homecare Market, By Region, 2020-2028 (USD Mllion)
21 Ambulatory Surgical Centers (ASCs) Market, By Region, 2020-2028 (USD Mllion)
22 Others Market, By Region, 2020-2028 (USD Mllion)
23 Regional Segment: Revenue Growth Analysis
24 Global Artificial Pancreas Market: Regional Analysis
25 North America Artificial Pancreas Market Overview
26 North America Artificial Pancreas Market, By Device Type
27 North America Artificial Pancreas Market, By End User
28 North America Artificial Pancreas Market, By Country
29 U.S. Artificial Pancreas Market, By Device Type
30 U.S. Artificial Pancreas Market, By End User
31 Canada Artificial Pancreas Market, By Device Type
32 Canada Artificial Pancreas Market, By End User
33 Mexico Artificial Pancreas Market, By Device Type
34 Mexico Artificial Pancreas Market, By End User
35 Four Quadrant Positioning Matrix
36 Company Market Share Analysis
37 Medtronic PLC: Company Snapshot
38 Medtronic PLC: SWOT Analysis
39 Medtronic PLC: Geographic Presence
40 Johnson & Johnson: Company Snapshot
41 Johnson & Johnson: SWOT Analysis
42 Johnson & Johnson: Geographic Presence
43 Tandem Diabetes Care, Inc.: Company Snapshot
44 Tandem Diabetes Care, Inc.: SWOT Analysis
45 Tandem Diabetes Care, Inc.: Geographic Presence
46 Pancreum, Inc: Company Snapshot
47 Pancreum, Inc: Swot Analysis
48 Pancreum, Inc: Geographic Presence
49 Bigfoot Biomedical, Inc.: Company Snapshot
50 Bigfoot Biomedical, Inc.: SWOT Analysis
51 Bigfoot Biomedical, Inc.: Geographic Presence
52 DEXCOM, INC.: Company Snapshot
53 DEXCOM, INC.: SWOT Analysis
54 DEXCOM, INC.: Geographic Presence
55 Beta Bionics, Inc. : Company Snapshot
56 Beta Bionics, Inc. : SWOT Analysis
57 Beta Bionics, Inc. : Geographic Presence
58 Admetsys Corp.: Company Snapshot
59 Admetsys Corp.: SWOT Analysis
60 Admetsys Corp.: Geographic Presence
61 Insulet Corporation, Inc.: Company Snapshot
62 Insulet Corporation, Inc.: SWOT Analysis
63 Insulet Corporation, Inc.: Geographic Presence
64 Defymed: Company Snapshot
65 Defymed: SWOT Analysis
66 Defymed: Geographic Presence
67 Other Companies: Company Snapshot
68 Other Companies: SWOT Analysis
69 Other Companies: Geographic Presence
The Global Artificial Pancreas Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Artificial Pancreas Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
